Crossmark

Anticancer drug therapy for patients with renal dysfunction

Crossref DOI link: https://doi.org/10.1007/s10147-023-02315-z

Published Online: 2023-03-28

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suyama, Koichi https://orcid.org/0000-0002-1788-1911
Miura, Yuji
License Information

Text and Data Mining valid from 2023-03-28

Version of Record valid from 2023-03-28
More Information

Article History

Received: 5 January 2023

Accepted: 10 February 2023

First Online: 28 March 2023

Declarations

:

: The authors declare no potential conflicts of interest.